• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运用分子建模、对接和 3D-QSAR 研究,确定苯并呋喃-3-基-(吲哚-3-基)马来酰亚胺作为 GSK-3β抑制剂的结合模式。

Use of molecular modeling, docking, and 3D-QSAR studies for the determination of the binding mode of benzofuran-3-yl-(indol-3-yl)maleimides as GSK-3beta inhibitors.

机构信息

Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, 60612, USA.

出版信息

J Mol Model. 2009 Dec;15(12):1463-79. doi: 10.1007/s00894-009-0498-x. Epub 2009 May 14.

DOI:10.1007/s00894-009-0498-x
PMID:19440740
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2955516/
Abstract

Molecular modeling and docking studies along with three-dimensional quantitative structure relationships (3D-QSAR) studies have been used to determine the correct binding mode of glycogen synthase kinase 3beta (GSK-3beta) inhibitors. The approaches of comparative molecular field analysis (CoMFA) and comparative molecular similarity index analysis (CoMSIA) are used for the 3D-QSAR of 51 substituted benzofuran-3-yl-(indol-3-yl)maleimides as GSK-3beta inhibitors. Two binding modes of the inhibitors to the binding site of GSK-3beta are investigated. The binding mode 1 yielded better 3D-QSAR correlations using both CoMFA and CoMSIA methodologies. The three-component CoMFA model from the steric and electrostatic fields for the experimentally determined pIC(50) values has the following statistics: R(2)(cv) = 0.386 nd SE(cv) = 0.854 for the cross-validation, and R(2) = 0.811 and SE = 0.474 for the fitted correlation. F (3,47) = 67.034, and probability of R(2) = 0 (3,47) = 0.000. The binding mode suggested by the results of this study is consistent with the preliminary results of X-ray crystal structures of inhibitor-bound GSK-3beta. The 3D-QSAR models were used for the estimation of the inhibitory potency of two additional compounds.

摘要

分子建模和对接研究以及三维定量构效关系(3D-QSAR)研究已被用于确定糖原合酶激酶 3β(GSK-3β)抑制剂的正确结合模式。比较分子场分析(CoMFA)和比较分子相似性指数分析(CoMSIA)方法被用于 51 个取代的苯并呋喃-3-基-(吲哚-3-基)马来酰亚胺作为 GSK-3β抑制剂的 3D-QSAR 研究。研究了抑制剂与 GSK-3β结合位点的两种结合模式。结合模式 1 采用 CoMFA 和 CoMSIA 方法均产生了更好的 3D-QSAR 相关性。来自立体和静电场的三组分 CoMFA 模型用于预测实验测定的 pIC(50)值,其统计数据如下:交叉验证的 R(2)(cv)= 0.386 nd SE(cv)= 0.854,拟合相关性的 R(2)= 0.811 和 SE = 0.474。F(3,47)= 67.034,R(2)的概率为 0(3,47)= 0.000。该研究结果提示的结合模式与抑制剂结合的 GSK-3β的初步 X 射线晶体结构结果一致。3D-QSAR 模型用于估计另外两种化合物的抑制活性。

相似文献

1
Use of molecular modeling, docking, and 3D-QSAR studies for the determination of the binding mode of benzofuran-3-yl-(indol-3-yl)maleimides as GSK-3beta inhibitors.运用分子建模、对接和 3D-QSAR 研究,确定苯并呋喃-3-基-(吲哚-3-基)马来酰亚胺作为 GSK-3β抑制剂的结合模式。
J Mol Model. 2009 Dec;15(12):1463-79. doi: 10.1007/s00894-009-0498-x. Epub 2009 May 14.
2
A new protocol for predicting novel GSK-3β ATP competitive inhibitors.一种预测新型 GSK-3β ATP 竞争抑制剂的新方案。
J Chem Inf Model. 2011 Jun 27;51(6):1431-8. doi: 10.1021/ci2001154. Epub 2011 Jun 9.
3
In silico design novel (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine derivatives as inhibitors for glycogen synthase kinase 3 based on 3D-QSAR, molecular docking and molecular dynamics simulation.基于 3D-QSAR、分子对接和分子动力学模拟,设计新型(5-咪唑-2-基-4-苯基嘧啶-2-基)[2-(2-吡啶基氨基)乙基]胺衍生物作为糖原合酶激酶 3 的抑制剂。
Comput Biol Chem. 2020 Oct;88:107328. doi: 10.1016/j.compbiolchem.2020.107328. Epub 2020 Jul 4.
4
From a natural product lead to the identification of potent and selective benzofuran-3-yl-(indol-3-yl)maleimides as glycogen synthase kinase 3beta inhibitors that suppress proliferation and survival of pancreatic cancer cells.从一种天然产物先导物出发,鉴定出强效且选择性的苯并呋喃-3-基-(吲哚-3-基)马来酰亚胺作为糖原合酶激酶3β抑制剂,其可抑制胰腺癌细胞的增殖和存活。
J Med Chem. 2009 Apr 9;52(7):1853-63. doi: 10.1021/jm801317h.
5
3D-QSAR and molecular docking studies on pyrazolopyrimidine derivatives as glycogen synthase kinase-3beta inhibitors.作为糖原合酶激酶-3β抑制剂的吡唑并嘧啶衍生物的3D-QSAR和分子对接研究
J Mol Graph Model. 2007 Mar;25(6):885-95. doi: 10.1016/j.jmgm.2006.08.009. Epub 2006 Sep 3.
6
Synthesis and biological evaluation of 3-([1,2,4]triazolo[4,3-a]pyridin-3-yl)-4-(indol-3-yl)-maleimides as potent, selective GSK-3β inhibitors and neuroprotective agents.3-([1,2,4]三唑并[4,3-a]吡啶-3-基)-4-(吲哚-3-基)-马来酰亚胺作为强效、选择性糖原合成酶激酶-3β抑制剂和神经保护剂的合成及生物学评价
Bioorg Med Chem. 2015 Mar 1;23(5):1179-88. doi: 10.1016/j.bmc.2014.12.026. Epub 2014 Dec 20.
7
3D-QSAR and molecular docking studies on 3-anilino-4-arylmaleimide derivatives as glycogen synthase kinase-3β inhibitors.3D-QSAR 和分子对接研究 3-苯胺基-4-芳基马来酰亚胺衍生物作为糖原合酶激酶-3β抑制剂。
Chem Biol Drug Des. 2012 Apr;79(4):560-71. doi: 10.1111/j.1747-0285.2011.01291.x. Epub 2012 Jan 30.
8
Glycogen synthase kinase-3 inhibition by 3-anilino-4-phenylmaleimides: insights from 3D-QSAR and docking.3-苯胺基-4-苯基马来酰亚胺对糖原合酶激酶-3的抑制作用:来自三维定量构效关系和对接的见解
J Comput Aided Mol Des. 2009 Feb;23(2):113-27. doi: 10.1007/s10822-008-9244-1. Epub 2008 Oct 7.
9
Synthesis and biological evaluation of novel 4-azaindolyl-indolyl-maleimides as glycogen synthase kinase-3beta (GSK-3beta) inhibitors.新型4-氮杂吲哚基-吲哚基-马来酰亚胺作为糖原合酶激酶-3β(GSK-3β)抑制剂的合成及生物学评价
Bioorg Med Chem. 2009 Jul 1;17(13):4302-12. doi: 10.1016/j.bmc.2009.05.031. Epub 2009 May 18.
10
Synthesis and preliminary characterization of radioiodinated benzofuran-3-yl-(indol-3-yl)maleimide derivatives as potential SPECT imaging probes for the detection of glycogen synthase kinase-3β (GSK-3β) in the brain.放射性碘化苯并呋喃-3-基-(吲哚-3-基)马来酰亚胺衍生物的合成与初步表征:作为用于检测脑中糖原合酶激酶-3β(GSK-3β)的潜在单光子发射计算机断层扫描(SPECT)成像探针
J Labelled Comp Radiopharm. 2016 Jun 30;59(8):317-21. doi: 10.1002/jlcr.3404. Epub 2016 Apr 29.

引用本文的文献

1
Integrated machine learning and deep learning-based virtual screening framework identifies novel natural GSK-3β inhibitors for Alzheimer's disease.基于机器学习和深度学习的集成虚拟筛选框架识别出用于阿尔茨海默病的新型天然GSK-3β抑制剂。
J Comput Aided Mol Des. 2025 Jul 16;39(1):53. doi: 10.1007/s10822-025-00637-w.
2
Pharmacophore-based screening and drug repurposing exemplified on glycogen synthase kinase-3 inhibitors.基于药效团的筛选和药物再利用:以糖原合酶激酶-3抑制剂为例
Mol Divers. 2017 May;21(2):385-405. doi: 10.1007/s11030-016-9724-5. Epub 2017 Jan 21.
3
Structure-guided design of a highly selective glycogen synthase kinase-3β inhibitor: a superior neuroprotective pyrazolone showing antimania effects.高选择性糖原合酶激酶-3β抑制剂的结构导向设计:一种具有抗躁狂作用的高效神经保护吡唑啉酮。
ChemMedChem. 2011 Sep 5;6(9):1587-92. doi: 10.1002/cmdc.201100231. Epub 2011 Jul 12.
4
From a natural product lead to the identification of potent and selective benzofuran-3-yl-(indol-3-yl)maleimides as glycogen synthase kinase 3beta inhibitors that suppress proliferation and survival of pancreatic cancer cells.从一种天然产物先导物出发,鉴定出强效且选择性的苯并呋喃-3-基-(吲哚-3-基)马来酰亚胺作为糖原合酶激酶3β抑制剂,其可抑制胰腺癌细胞的增殖和存活。
J Med Chem. 2009 Apr 9;52(7):1853-63. doi: 10.1021/jm801317h.

本文引用的文献

1
From a natural product lead to the identification of potent and selective benzofuran-3-yl-(indol-3-yl)maleimides as glycogen synthase kinase 3beta inhibitors that suppress proliferation and survival of pancreatic cancer cells.从一种天然产物先导物出发,鉴定出强效且选择性的苯并呋喃-3-基-(吲哚-3-基)马来酰亚胺作为糖原合酶激酶3β抑制剂,其可抑制胰腺癌细胞的增殖和存活。
J Med Chem. 2009 Apr 9;52(7):1853-63. doi: 10.1021/jm801317h.
2
9-cyano-1-azapaullone (cazpaullone), a glycogen synthase kinase-3 (GSK-3) inhibitor activating pancreatic beta cell protection and replication.9-氰基-1-氮杂泡林(cazpaullone),一种糖原合酶激酶-3(GSK-3)抑制剂,可激活胰腺β细胞保护和复制。
J Med Chem. 2008 Apr 10;51(7):2196-207. doi: 10.1021/jm701582f. Epub 2008 Mar 18.
3
Pharmacophore modeling, quantitative structure-activity relationship analysis, and in silico screening reveal potent glycogen synthase kinase-3beta inhibitory activities for cimetidine, hydroxychloroquine, and gemifloxacin.药效团建模、定量构效关系分析和计算机模拟筛选揭示了西咪替丁、羟氯喹和吉米沙星对糖原合酶激酶-3β具有强效抑制活性。
J Med Chem. 2008 Apr 10;51(7):2062-77. doi: 10.1021/jm7009765. Epub 2008 Mar 7.
4
Preclinical efficacy on GSK-3 inhibitors: towards a future generation of powerful drugs.GSK-3抑制剂的临床前疗效:迈向新一代强效药物
Med Res Rev. 2008 Sep;28(5):773-96. doi: 10.1002/med.20119.
5
Novel GSK-3beta inhibitors from sequential virtual screening.通过连续虚拟筛选获得的新型糖原合成酶激酶-3β抑制剂
Bioorg Med Chem. 2008 Jan 15;16(2):636-43. doi: 10.1016/j.bmc.2007.10.047. Epub 2007 Oct 22.
6
Probing novel 1-aza-9-oxafluorenes as selective GSK-3beta inhibitors.探索新型1-氮杂-9-氧杂芴作为选择性糖原合成酶激酶-3β抑制剂。
ChemMedChem. 2008 Jan;3(1):120-6. doi: 10.1002/cmdc.200700175.
7
Design and synthesis of 7-hydroxy-1H-benzoimidazole derivatives as novel inhibitors of glycogen synthase kinase-3beta.7-羟基-1H-苯并咪唑衍生物作为糖原合酶激酶-3β新型抑制剂的设计与合成
Bioorg Med Chem Lett. 2007 Oct 15;17(20):5686-9. doi: 10.1016/j.bmcl.2007.07.056. Epub 2007 Aug 19.
8
Glycogen synthase kinase-3 (GSK-3) inhibitory activity and structure-activity relationship (SAR) studies of the manzamine alkaloids. Potential for Alzheimer's disease.曼氏生物碱的糖原合酶激酶-3(GSK-3)抑制活性及构效关系(SAR)研究。对阿尔茨海默病的潜在作用。
J Nat Prod. 2007 Sep;70(9):1397-405. doi: 10.1021/np060092r. Epub 2007 Aug 21.
9
Outliers in SAR and QSAR: 2. Is a flexible binding site a possible source of outliers?SAR和QSAR中的异常值:2. 灵活的结合位点可能是异常值的来源吗?
J Comput Aided Mol Des. 2007 Aug;21(8):421-35. doi: 10.1007/s10822-007-9126-y. Epub 2007 Jul 24.
10
Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. possible new GSK-3beta therapies for bipolar disorders.基于结构的设计促成了锂模拟物的发现,这些模拟物可阻断啮齿动物的躁狂样效应。双相情感障碍可能的新型GSK-3β疗法。
J Am Chem Soc. 2007 Jul 4;129(26):8328-32. doi: 10.1021/ja068969w. Epub 2007 Jun 7.